1. Home
  2. COCP vs OPI Comparison

COCP vs OPI Comparison

Compare COCP & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • OPI
  • Stock Information
  • Founded
  • COCP 2006
  • OPI 2009
  • Country
  • COCP United States
  • OPI United States
  • Employees
  • COCP N/A
  • OPI N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • OPI Real Estate Investment Trusts
  • Sector
  • COCP Health Care
  • OPI Real Estate
  • Exchange
  • COCP Nasdaq
  • OPI Nasdaq
  • Market Cap
  • COCP 15.7M
  • OPI 16.6M
  • IPO Year
  • COCP N/A
  • OPI 2009
  • Fundamental
  • Price
  • COCP $1.80
  • OPI $0.26
  • Analyst Decision
  • COCP Strong Buy
  • OPI
  • Analyst Count
  • COCP 1
  • OPI 0
  • Target Price
  • COCP $6.00
  • OPI N/A
  • AVG Volume (30 Days)
  • COCP 21.6K
  • OPI 1.1M
  • Earning Date
  • COCP 08-13-2025
  • OPI 07-30-2025
  • Dividend Yield
  • COCP N/A
  • OPI 14.81%
  • EPS Growth
  • COCP N/A
  • OPI N/A
  • EPS
  • COCP N/A
  • OPI N/A
  • Revenue
  • COCP N/A
  • OPI $476,159,000.00
  • Revenue This Year
  • COCP N/A
  • OPI N/A
  • Revenue Next Year
  • COCP N/A
  • OPI N/A
  • P/E Ratio
  • COCP N/A
  • OPI N/A
  • Revenue Growth
  • COCP N/A
  • OPI N/A
  • 52 Week Low
  • COCP $1.12
  • OPI $0.18
  • 52 Week High
  • COCP $3.26
  • OPI $3.02
  • Technical
  • Relative Strength Index (RSI)
  • COCP 69.71
  • OPI 52.40
  • Support Level
  • COCP $1.46
  • OPI $0.26
  • Resistance Level
  • COCP $1.60
  • OPI $0.34
  • Average True Range (ATR)
  • COCP 0.08
  • OPI 0.03
  • MACD
  • COCP 0.02
  • OPI 0.01
  • Stochastic Oscillator
  • COCP 92.31
  • OPI 46.23

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About OPI Office Properties Income Trust of Beneficial Interest

Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.

Share on Social Networks: